Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2025-12-24 @ 10:14 PM
NCT ID:
NCT01756235
Eligibility Criteria:
Inclusion Criteria:
* Had rheumatoid arthritis (RA) and is eligible to start and/or continue adalimumab therapy according to the local product label and prescription guidelines
* Had been started on adalimumab therapy no more than one (1) month prior to the study enrolment
* Had negative result of tuberculosis (TB) screening test or was receiving TB prophylaxis as per local guidelines
* Had provided written Authorization to the investigator to use and/or disclose personal and/or health data, or Informed Consent if requested by the Local Regulations
Exclusion Criteria:
* Was unable to walk either due to RA or a comorbid condition
* Was unable to perform basic self-care activities
* Had contraindications for treatment with adalimumab
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01756235
Study Brief:
Protocol Section:
NCT01756235